(Q40149484)

17 September 2017

1 reference

title

Bromocriptine: endocrine pharmacology and therapeutic applications (English)

1 reference

17 September 2017

1 reference

R. L. Barbieri

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343126

3 October 2023

K. J. Ryan

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343126

3 October 2023

language of work or name

English

0 references

publication date

1 June 1983

1 reference

full work available at URL

17 September 2017

https://doi.org/10.1016/s0015-0282(16)47109-8

online access status

open access

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A6343126

https://api.elsevier.com/content/article/PII:S0015028216471098?httpAccept=text/xml

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

https://api.elsevier.com/content/article/PII:S0015028216471098?httpAccept=text/plain

3 October 2023

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

3 October 2023

published in

Fertility and Sterility

1 reference

17 September 2017

39

1 reference

17 September 2017

6

1 reference

17 September 2017

727-741

1 reference

A radioimmunoassay for human prolactin

17 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effect of Anterior Pituitary Perfusion and Intraventricular Injection of Catecholamines on Prolactin Release1

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Incidence and significance of hyperprolactinaemia in women with amenorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Ergotoxine inhibition of deciduoma formation and its reversal by progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Maintenance of gestation of ergotoxine-treated pregnant rats by exogenous prolactin.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

[2-Br-alpha-ergokryptin: influence on fertility and lactation in the rat]

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Pharmacology of Bromocriptine in Health and Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

A broad spectrum of prolactin suppression by bromocriptine in hyperprolactinemic women: a study of serum prolactin and bromocriptine levels after acute and chronic admknistration of bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

3H-spiroperidol labels dopamine receptors in pituitary and brain

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Human pituitary prolactin (hPRL): the entire linear amino acid sequence

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin of apparent large molecular size: the major immunoactive prolactin component in plasma of a patient with a pituitary tumor

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Size heterogeneity of human prolactin in CSF and serum: experimental conditions that alter gel filtration patterns

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Size heterogeneity of immunoreactive prolactin in hyperprolactinaemic serum

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Binding of dopamine to bovine anterior pituitary gland membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Studies on the Mechanism of the Dopamine-Mediated Inhibition of Prolactin Secretion1

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Dopamine Levels in Hypophysial Stalk Blood in the Rat are Sufficient to Inhibit Prolactin SecretionIn Vivo*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin response to thyrotropin releasing hormone in normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Stimulatory effects of gamma-hydroxybutyric acid on growth hormone and prolactin release in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Relation of sleep-entrained human prolactin release to REM-nonREM cycles

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin levels during the menstrual cycle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Pattern of increase in circulating prolactin levels during human gestation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effects of prolactin on the sensitivity of the testis to LH

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Luteal 20α-hydroxy steroid dehydrogenase and the formation of Δ4-3-oxo steroids in the rat after weaning or treatment with 2-bromo-α-ergocryptine during lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Multiple receptors for dopamine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effects of prolactin and ergot alkaloids on the tubero-infundibular dopamine (DA) neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Central dopamine agonistic activity and microsomal biotransformation of lisuride, lergotrile and bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine inhibits colony formation by rat pituitary tumor cells in a double-layered agar clonogenic assay

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

The mode of action of bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromoergocryptine-induced prolactin degradation in cultured pituitary cells

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effect of bromocriptine on DNA synthesis, growth and hormone secretion of spontaneous pituitary tumours in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effects of oestrogen and bromocryptine on in vivo secretion and mitosis in prolactin cells

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Synthesis of DNA in oestrogen-induced pituitary tumurs in rats: effect of bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Synergism of estrogen and bromergocryptine in the induction of luteolysis in cynomolgus monkeys (Macaca fascicularis)

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine treatment during early human pregnancy: effect on the levels of prolactin, sex steroids and placental lactogen

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Pulsatile gonadotrophin secretion in hyperprolactinaemic amenorrhoea an the response to bromocriptine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Restoration of oestrogen positive feedback effect on LH release by bromocriptine in hyperprolactinaemic patients with galactorrhoea-amenorrhoea

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin-secreting pituitary adenomas in women. IV. Pituitary function in amenorrhea associated with normal or abnormal serum prolactin and sellar polytomography

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effects of a dopamine antagonist on the release of gonadotropin and prolactin in normal women and women with hyperprolactinemic anovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

The Inhibitory Effect of Dopamine Agonists on LH Release in Women1

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Metoclopramide-induced hyperprolactinemia impairs ovarian follicle maturation and corpus luteum function in women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Relationship between the endocrine environment within the Graafian follicle and the subsequent rate of progesterone secretion by human granulosa cells in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin inhibits oestrogen synthesis in the ovary

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin Inhibition of Luteinizing Hormone-Stimulated Androgen Synthesis in Ovarian Interstitial Cells Cultured in Defined Medium: Mechanism of Action*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

A possible role for prolactin in control of steroid secretion by the human Graafian follicle

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Induction of Ovulation in Women with Hyperprolactinemic Amenorrhea Using Clomiphene and Human Chorionic Gonadotropin or Bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Galactorrhea: a study of 235 cases, including 48 with pituitary tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Endocrine abnormalities in patients undergoing long-term hemodialysis. The role of prolactin

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Ovarian function in chronic renal failure: evidence suggesting hypothalamic anovulation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Failure of naloxone to alter growth hormone and prolactin levels in acromegalic and in hyperprolactinaemic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Serum prolactin responses to metoclopramide in Cushing's syndrome and Nelson's syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin-secreting pituitary adenomas in women. VI. Absence of demonstrable adenomas in patients with altered menstrual function and abnormal sellar polytomography

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Normal Variants of the Sella Turcica

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

The value of the thyrotropin-releasing hormone test in patients with prolactin-secreting pituitary tumors and suprasellar non-pituitary tumors.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Validity of hypothalamic-pituitary testing in hyperprolactinemia: prolactin responses to insulin hypoglycemia and arginine.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Longitudinal evaluation of patients with untreated prolactin-secreting pituitary adenomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Spontaneous development of hyperprolactinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine mesylate (Parlodel) in the management of amenorrhea/galactorrhea associated with hyperprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Computed tomographic demonstration of the effects of bromocriptine on pituitary microadenoma size

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effect of treatment with bromocriptine on the size and activity of prolactin producing pituitary tumours.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Size Reduction of Macroprolactinomas by Bromocriptine or Lisuride Treatment*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine Reduction of Prolactinoma Size

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Size reduction of extrasellar pituitary tumors during bromocriptine treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Conservative management of pituitary prolactinomas; evidence for bromocriptine-induced regression

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine reduces pituitary tumor size and hypersection. Requiem for pituitary surgery?

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Rapid Changes of Prolactinoma Volume after Withdrawal and Reinstitution of Bromocriptine*

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Prolactin-secreting pituitary adenomas in women. II. Menstrual function, pituitary reserves, and prolactin production following microsurgical removal

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Surgical treatment of prolactin-secreting microadenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Changes in pituitary hormones during and following transsphenoidal removal of prolactinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Predictors of the outcome of transsphenoidal surgery for prolactin-secreting pituitary adenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Persistent defect in regulation of prolactin secretion after successful pituitary tumor removal in women with the galactorrhea-amenorrhea syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Effect of long-term bromocriptine infusion on plasma prolactin and ovine chorionic somatomammotropin in the pregnant ewe and fetal sheep

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Normal Pregnancies after Treatment of Hyperprolactinemia with Bromoergocryptine, Despite Suspected Pituitary Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

The effect of pregnancy and lactation on pituitary prolactin-secreting tumours

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

The Incidence of Complications During Pregnancy after Treatment of Hyperprolactinemia with Bromocriptine in Patients with Radiologically Evident Pituitary Tumors

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Pregnancies in women with hyperprolactinaemia: clinical course and obstetric complications of 41 pregnancies in 27 women

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Pregnancy in patients presenting with hyperprolactinaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Clinical course and outcome of pregnancy in twenty-five patients with pituitary microadenomas

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

The effect of pregnancy on suspected pituitary adenomas after conservative management of ovulation defects associated with galactorrhea

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Pituitary tumours during pregnancy in mothers treated with bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine as prophylactic therapy in prolactinoma during pregnancy

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Mechanisms of bromocriptine-induced hallucinations

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Alcohol increases bromocriptine's side effects

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Side effects of bromocriptine

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

A comparative controlled study of hormones used in the prevention of postpartum breast engorgement and lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Puerperal thrombo-embolism and suppression of lactation

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine Treatment of the Premenstrual Syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Bromocriptine treatment of oligospermia: a double blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

A rationale for the use of bromocriptine in patients with amenorrhea and normoprolactinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Value of bromocriptine in unexplained primary infertility: a double-blind controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0015-0282%2816%2947109-8

7 January 2021

Neuropharmacological investigations with two ergot alkaloids, Hydergine and bromocriptine

9

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Prolactin-secreting pituitary adenomas: transsphenoidal microsurgical treatment

3 October 2023

16

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Recent studies on functions and control of prolactin secretion in rats

3 October 2023

25

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Pattern of sexual steroids, prolactin, and gonadotropic hormones during prolactin inhibition in normally cycling women

3 October 2023

47

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Outcome of Pregnancy in Women with Pituitary Adenoma

3 October 2023

61

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Effects of large doses of estrogen on prolactin and growth hormone release

3 October 2023

63

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

The effect of metoclopramide, TRH and L-dopa on prolactin secretion in pituitary adenoma and in "functional" galactorrhoea syndrome

3 October 2023

75

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Pituitary Function Following Surgery for Prolactinomas

3 October 2023

92

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Bromocriptine mesylate for prevention of postpartum lactation

3 October 2023

115

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Successful treatment of polycystic ovary syndrome with spironolactone or bromocriptine

3 October 2023

117

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

Bromocriptine in the treatment of premenstrual tension syndrome

3 October 2023

120

1 reference

https://api.crossref.org/works/10.1016/S0015-0282(16)47109-8

3 October 2023

Identifiers

0 references

1 reference